Page 341 - IJB-10-6

International Journal of Bioprinting 3D-printed PPDO/GO stents for CHD treatment

Funding review and meta-analysis of 260 studies. Int J Epidemiol.
2019;48(2):455-463.
This work was funded by the National Natural Science doi: 10.1093/ije/dyz009
Foundation of China (grant number 82300344), Shanghai
Shenkang Hospital Development Center Program (grant 3. Baerlocher L, Kretschmar O, Harpes P, Arbenz U, Berger F,
Knirsch W. Stent implantation and balloon angioplasty for
number SHDC22021209), and Xinhua Hospital Affiliated treatment of branch pulmonary artery stenosis in children.
to Shanghai Jiao Tong University School of Medicine- Clin Res Cardiol. 2008;97(5):310-317.
Shanghai Jiao Tong University Institute of Medical doi: 10.1007/s00392-007-0631-8
Robotics Joint Program (grant number 21XJMR01).
4. Balasubramanian S, Marshall AC, Gauvreau K, et al.
Conflict of interest Outcomes after stent implantation for the treatment of
congenital and postoperative pulmonary vein stenosis in
The authors declared no conflict of interest. children. Circ Cardiovasc Interv. 2012;5(1):109-117.
doi: 10.1161/CIRCINTERVENTIONS.111.964189
Author contributions 5. Forbes TJ, Kim DW, Du W, et al. Comparison of surgical,
stent, and balloon angioplasty treatment of native coarctation
Conceptualization: Enrong Chen, Xiji Qin, Jing Sun, of the aorta. J Am Coll Cardiol. 2011;58(25):2664-2674.
Kun Sun doi: 10.1016/j.jacc.2011.08.053
Formal analysis: Enrong Chen, Xiji Qin
Funding acquisition: Xuejun Jin, Kun Sun 6. Lezo JSd, Romero M, Pan M, et al. Stent repair for complex
Investigation: Enrong Chen, Xiji Qin, Zhihui Xiong, coarctation of aorta. J Am Coll Cardiol Intv. 2015;8(10):
1368-1379.
Methodology: Enrong Chen, Xiji Qin, Xiaorong Cai, Zhihui doi: 10.1016/j.jcin.2015.05.018
Xiong, Jing Sun
Resources: Xuejun Jin, Jing Sun, Kun Sun 7. Moore JW, Spicer RL, Perry JC, et al. Percutaneous use
Supervision: Zhihui Xiong, Jing Sun, Kun Sun of stents to correct pulmonary artery stenosis in young
Writing – original graft: Enrong Chen, Xiji Qin children after cavopulmonary anastomosis. Am Heart J.
1995;130(6):1245-1249.
Writing – review & editing: Enrong Chen, Xiji Qin, doi: 10.1016/0002-8703(95)90149-3
Xiaorong Cai, Zhihui Xiong, Jing Sun
8. Ing F. Stents: what’s available to the pediatric interventional
Ethics approval and consent to participate cardiologist? Catheter Cardiovasc Interv. 2002;57(3):
374-386.
The animal experiments in this study were approved doi: 10.1002/ccd.10342
by the Animal Ethics Committee of Xinhua Hospital 9. Wiebe J, Nef HM, Hamm CW. Current status of bioresorbable
Affiliated to Shanghai Jiao Tong University School of scaffolds in the treatment of coronary artery disease. J Am
Medicine (XHEC-F-2024-079), and all procedures were Coll Cardiol. 2014;64(23):2541-2551.
performed in strict accordance with the regulations of the doi: 10.1016/j.jacc.2014.09.041
Animal Ethics Committee of Xinhua Hospital Affiliated to 10. McMahon S, Bertollo N, Cearbhaill EDO, et al. Bio-
Shanghai Jiao Tong University School of Medicine. resorbable polymer stents: a review of material progress and
prospects. Prog Polymer Sci. 2018;83:79-96.
Consent for publication doi: 10.1016/j.progpolymsci.2018.05.002
Not applicable. 11. Sotomi Y, Onuma Y, Collet C, et al. Bioresorbable scaffold.
Circ Res. 2017;120(8):1341-1352.
Availability of data doi: 10.1161/CIRCRESAHA.117.310275
Data is available from the corresponding authors upon 12. Shibbani K, De Lima e Silva Bagno L, Poulin M-F, et al.
reasonable request. Preclinical comparative assessment of a dedicated pediatric
poly-L-lactic-acid-based bioresorbable scaffold with a
References low-profile bare metal stent. Catheter Cardiovasc Interv.
2020;96(4):878-888.
doi: 10.1002/ccd.28893
1. Su Z, Zou Z, Hay SI, et al. Global, regional, and national time
trends in mortality for congenital heart disease, 1990–2019: 13. Wright J, Nguyen A, D’Souza N, et al. Bioresorbable stent
an age-period-cohort analysis for the Global Burden of to manage congenital heart defects in children. Materialia.
Disease 2019 study. eClinicalMedicine. 2022;43:101249. 2021;16:101078.
doi: 10.1016/j.eclinm.2021.101249 doi: 10.1016/j.mtla.2021.101078
2. Liu Y, Chen S, Zühlke L, et al. Global birth prevalence of 14. Bowen PK, Guillory RJ, Shearier ER, et al. Metallic zinc
congenital heart defects 1970–2017: updated systematic exhibits optimal biocompatibility for bioabsorbable

Volume 10 Issue 6 (2024) 333 doi: 10.36922/ijb.4530